399 related articles for article (PubMed ID: 30722079)
21. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
Zhu S; Chen J; Diamond SL
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
[TBL] [Abstract][Full Text] [Related]
22. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
23. Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
Whyte CS; Mostefai HA; Baeten KM; Lucking AJ; Newby DE; Booth NA; Mutch NJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672724
[TBL] [Abstract][Full Text] [Related]
24. Contact Pathway Function During Human Whole Blood Clotting on Procoagulant Surfaces.
Zhu S; Herbig BA; Yu X; Chen J; Diamond SL
Front Med (Lausanne); 2018; 5():209. PubMed ID: 30083534
[TBL] [Abstract][Full Text] [Related]
25. Fibrinolysis in Platelet Thrombi.
Kanji R; Gue YX; Memtsas V; Gorog DA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066261
[TBL] [Abstract][Full Text] [Related]
26. Repeated Social Defeat Exaggerates Fibrin-Rich Clot Formation by Enhancing Neutrophil Extracellular Trap Formation via Platelet-Neutrophil Interactions.
Sugimoto T; Yamada H; Wada N; Motoyama S; Saburi M; Kubota H; Miyawaki D; Wakana N; Kami D; Ogata T; Ibi M; Matoba S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943852
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance.
Peña-Martínez C; Durán-Laforet V; García-Culebras A; Ostos F; Hernández-Jiménez M; Bravo-Ferrer I; Pérez-Ruiz A; Ballenilla F; Díaz-Guzmán J; Pradillo JM; Lizasoain I; Moro MA
Stroke; 2019 Nov; 50(11):3228-3237. PubMed ID: 31526124
[TBL] [Abstract][Full Text] [Related]
28. Microfluidic and computational study of structural properties and resistance to flow of blood clots under arterial shear.
Mitrophanov AY; Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J
Biomech Model Mechanobiol; 2019 Oct; 18(5):1461-1474. PubMed ID: 31055691
[TBL] [Abstract][Full Text] [Related]
29. Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.
Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J; Mitrophanov AY
Biophys J; 2018 Feb; 114(4):978-991. PubMed ID: 29490257
[TBL] [Abstract][Full Text] [Related]
30. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
31. DNAse-dependent, NET-independent pathway of thrombus formation in vivo.
Carminita E; Crescence L; Brouilly N; Altié A; Panicot-Dubois L; Dubois C
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34260389
[TBL] [Abstract][Full Text] [Related]
32. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa.
Chen J; Diamond SL
PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558
[TBL] [Abstract][Full Text] [Related]
33. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
[TBL] [Abstract][Full Text] [Related]
34. Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.
Pujadas-Mestres L; Lopez-Vilchez I; Arellano-Rodrigo E; Reverter JC; Lopez-Farre A; Diaz-Ricart M; Badimon JJ; Escolar G
PLoS One; 2017; 12(2):e0171486. PubMed ID: 28192448
[TBL] [Abstract][Full Text] [Related]
35. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
[TBL] [Abstract][Full Text] [Related]
36. Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.
Sugita C; Yamashita A; Moriguchi-Goto S; Furukoji E; Takahashi M; Harada A; Soeda T; Kitazawa T; Hattori K; Tamura S; Asada Y
Thromb Res; 2009 Nov; 124(5):601-7. PubMed ID: 19660789
[TBL] [Abstract][Full Text] [Related]
37. Transport physics and biorheology in the setting of hemostasis and thrombosis.
Brass LF; Diamond SL
J Thromb Haemost; 2016 May; 14(5):906-17. PubMed ID: 26848552
[TBL] [Abstract][Full Text] [Related]
38. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
39. Activated α
Constantinescu-Bercu A; Grassi L; Frontini M; Salles-Crawley II; Woollard K; Crawley JT
Elife; 2020 Apr; 9():. PubMed ID: 32314961
[TBL] [Abstract][Full Text] [Related]
40. Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots.
Zubairova LD; Nabiullina RM; Nagaswami C; Zuev YF; Mustafin IG; Litvinov RI; Weisel JW
Sci Rep; 2015 Dec; 5():17611. PubMed ID: 26635081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
